Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular genetics of the N-acetyltransferases.

× No keyword cloud information.

17 in total

1. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid.

Authors: C A Smith; M Wadelius; A C Gough; D J Harrison; C R Wolf; A Rane
Journal: J Med Genet Date: 1997-09 Impact factor: 6.318

Review 2. Assessment of liver metabolic function. Clinical implications.

Authors: J Brockmöller; I Roots
Journal: Clin Pharmacokinet Date: 1994-09 Impact factor: 6.447

Review 3. Pharmacogenetics of cancer therapy: getting personal.

Authors: E Y Krynetski; W E Evans
Journal: Am J Hum Genet Date: 1998-07 Impact factor: 11.025

4. N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.

Authors: A L Hubbard; D J Harrison; C Moyes; A H Wyllie; C Cunningham; E Mannion; C A Smith
Journal: Gut Date: 1997-08 Impact factor: 23.059

Review 5. Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm.

Authors: E Y Krynetski; W E Evans
Journal: Pharm Res Date: 1999-03 Impact factor: 4.200

Review 6. Mechanisms of unpredictable adverse drug reactions.

Authors: M J Rieder
Journal: Drug Saf Date: 1994-09 Impact factor: 5.606

7. Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro.

Authors: S L Kelly; E Sim
Journal: Biochem J Date: 1994-09-01 Impact factor: 3.857

8. Assessment of arylamine N-acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients.

Authors: A E Cribb; B Tsui; R Isbrucker; R T Michael; C T Gillespie; J Brown-Bonomo; P Barrett; T Levatte; K W Renton
Journal: Br J Clin Pharmacol Date: 1995-01 Impact factor: 4.335

9. Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism.

Authors: Masashi Yabuki; Yutaka Kon-Ya; Masaki Kataoka; Takeshi Shimizudani; Kyoko Akao; Masaki Ito; Hiroshi Kanamaru; Iwao Nakatsuka
Journal: Eur J Drug Metab Pharmacokinet Date: 2003 Jan-Mar Impact factor: 2.441

10. Probing the catalytic potential of the hamster arylamine N-acetyltransferase 2 catalytic triad by site-directed mutagenesis of the proximal conserved residue, Tyr190.

Authors: Xin Zhou; Naixia Zhang; Li Liu; Kylie J Walters; Patrick E Hanna; Carston R Wagner
Journal: FEBS J Date: 2009-10-23 Impact factor: 5.542